AOK Bayern - Die Gesundheitskasse
Germany · 426 open tenders · 1,752 documented awards
Current tenders
AOK Hof - Replacement New Building - General Contractor
Deadline 7 Oct ·
AOK Hof - Replacement Building - General Contractor
8.500.000 €Deadline 7 Oct ·
AOK Hof - Replacement New Construction - General Contractor
BELOW THRESHOLDDeadline 7 Oct ·
Video consultation
Deadline 9 Oct ·
Video consultation
2.600.500 €Deadline 9 Oct ·
Contract for Call Center Services for Insured Communication Provision Contracts
Deadline 15 Oct ·
Contract for Call Center Services for Insured Communication Provision Contracts
3.108.000 €Deadline 15 Oct ·
Open house drug rebate agreements Tocilizumab, ATC L04AC07
Deadline 5 Nov ·
Open house Arzneimittelrabattverträge Lipegfilgrastim, ATC L03AA14
Deadline 5 Nov ·
Open house Pharmaceutical Rebate Agreements Lipegfilgrastim, ATC L03AA14
Deadline 5 Nov ·
Open house Tocilizumab drug discount agreements, ATC L04AC07
Deadline 5 Nov ·
Open house Pharmaceutical Discount Contracts Buserelin, ATC L02AE01
Deadline 5 Dec ·
Open house pharmaceutical discount agreements Tapentadol in non-retarded pharmaceutical forms, ATC N02AX06
Deadline 5 Dec ·
Open house pharmaceutical discount agreements Trentino, ATC A16AX12
Deadline 5 Dec ·
Open house Drug Discount Agreements Carbamazepine, ATC N03AF01
Deadline 5 Dec ·
Open house medicinal discount contracts Trentino, ATC A16AX12
Deadline 5 Dec ·
Open house Pharmaceutical Rebate Agreements Carbamazepine, ATC N03AF01
Deadline 5 Dec ·
Open house Pharmaceutical Rebate Agreements Tapentadol in non-extended-release formulations, ATC N02AX06
Deadline 5 Dec ·
Open house Pharmaceutical Discount Agreements Buserelin, ATC L02AE01
Deadline 5 Dec ·
Open house drug rebate contracts Botulinum toxin type A, finished pharmaceutical product name Xeomin(R), ATC M03AX21
Deadline 5 Jan ·
Open house Pharmaceutical Discount Agreements Goserelin, ATC L02AE03
Deadline 5 Jan ·
Open house Pharmaceutical Discount Agreements Colecalciferol, non RX, exclusively products prescribable according to Annex 1 AM-RL G-BA, ATC A11CC05
Deadline 5 Jan ·
Open house pharmaceutical discount agreements Nilotinib, ATC L01EA03 (excluding Nilotinib dispersed in applesauce, unless the manufacturer has patent protection for this)
Deadline 5 Jan ·
Open house Pharmaceutical Discount Agreements Cholecalciferol, non-prescription, exclusively products eligible for prescription according to Appendix 1 AM-RL G-BA, ATC A11CC05
Deadline 5 Jan ·
Open house Pharmaceutical Rebate Agreements Botulinum Toxin Type A, Finished Pharmaceutical Product Name Xeomin(R), ATC M03AX21
Deadline 5 Jan ·
Open house Drug Discount Agreements Goserelin, ATC L02AE03
Deadline 5 Jan ·
Open house Pharmaceutical Discount Agreements Nilotinib, ATC L01EA03 (excluding Nilotinib dispersed in applesauce, unless the manufacturer enjoys patent protection for this)
Deadline 5 Jan ·
Open house Pharmaceutical discount agreements Brinzolamide and Brimonidine, ATC S01EC24
Deadline 5 Feb ·
Open House Pharmaceutical Rebate Agreements Rotigotine, ATC N04BC09
Deadline 5 Feb ·
Open house Opipramol pharmaceutical rebate agreements, ATC N06AA05
Deadline 5 Feb ·
Purchasing rhythm
Awards per year — who knows the rhythm prepares before the notice appears.
2018179
2019278
2020375
2021209
2022239
2023345
2024551
2025624
2026366
Clement What the numbers say about this buyer
- 72% of this buyer's awards went to companies that had already won here before (1,127 awards since 2017, spread over 321 companies). That is well above the national norm (45%) — newcomers have a harder time here than elsewhere.n = 1,127 awards since 2017
- The median procedure drew just one bid (1,070 procedures with a bid count); 78% ended with a single bidder. Country: median 3.1 bids.n = 1,070
- The award came in at a median 98% of the estimated value (5 awards with both estimate and value) — pricing at the estimate is usually about right here. Country: 86%.n = 5
- From notice to award takes a median 42 days here (85 procedures). Country: 91 days.n = 85
- Across 151 procedures with structured selection criteria, this buyer most often required: Trade register enrolment (146 of 151), References: services (5 of 151), Technical staff for execution (4 of 151), Professional liability insurance (4 of 151).n = 151
- 66% of the bids received came from small and medium-sized enterprises (16 procedures with a bid mix). Country: 75%.n = 16
- 0% of the bids received came from other countries (16 procedures with a bid mix) — all bidders, not just the winners. Country: 3%.n = 16
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 04/10/2026.
Expected next awards
From the rhythm of past awards per sector — an expectation, not an announcement. Hit rate so far: 26% of 11,200 closed expectation windows produced a notice.
- Sept 2026Business services
about every 3 months · 69 awards · last Jun 2026 to FUNKE Works GmbH - Sept 2026Cleaning, environment & waste
about every 3 months · 51 awards · last Jun 2026 to Geiger FM Reinigung Süd GmbH - Oct 2026Transport equipment
about every 10 months · 9 awards · last Dec 2025 to Automobil - Nov 2026Medical equipment & pharma
about every 1 months · 810 awards · last Sept 2026 to Ipsen Pharma GmbH - Dec 2026Architecture & engineering
about every 25 months · 13 awards · last Nov 2024 to Ingenieurbüro Koppe GmbH - May 2027IT services
about every 8 months · 9 awards · last Aug 2026 to NAXCON GmbH
Who has won here before
| Company | Awards | Period |
|---|---|---|
| ratiopharm GmbH | 56 | 2014–2023 |
| Hexal AG · Holzkirchen | 46 | 2011–2022 |
| Aliud Pharma GmbH · Laichingen | 45 | 2011–2023 |
| Haemato Pharm GmbH · Schönefeld | 43 | 2014–2022 |
| Orifarm GmbH · Leverkusen | 39 | 2018–2023 |
| kohlpharma GmbH · Merzig | 38 | 2015–2023 |
| CC Pharma GmbH · Densborn | 37 | 2016–2023 |
| axicorp Pharma B.V. · EC Den Haag | 36 | 2019–2023 |
| Abacus Medicine A/S · Kopenhagen | 35 | 2017–2023 |
| TAD Pharma GmbH · Cuxhaven | 33 | 2011–2023 |
From 18.0M documented awards · regular winners know this buyer's requirements — that is your competition.